In March 2025, the company declared new plans to get a direct-to-purchaser providing of its Wegovy weight loss drug. The company proven a new pharmacy, called NovoCare, which might demand clients $499 every month for entry to the drug, a lot less than fifty percent the cost of the drug by means of other pharmaceutical distribution networks.[53]The